• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by BCTG Acquisition Corp.

    4/26/21 4:30:59 PM ET
    $BCTG
    Business Services
    Finance
    Get the next $BCTG alert in real time by email
    SC 13G 1 d172321dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No.     )*

     

     

    BCTG Acquisition Corp.

    (Name of Issuer)

    Common Stock,

    par value $0.0001 per share

    (Title of Class of Securities)

    05492W 103

    (CUSIP Number)

    April 14, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


      1   

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Southpoint Master Fund, LP

      2  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☒

     

      3  

    SEC Use Only

     

        

      4  

    Citizenship or Place of Organization.

     

    Cayman Islands

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5    

    Sole Voting Power

     

    0 shares

       6   

    Shared Voting Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

       7   

    Sole Dispositive Power

     

    0 shares

       8   

    Shared Dispositive Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

      9  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,906,380 shares

     

    Refer to Item 4 below.

    10  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐  N/A

     

        

    11  

    Percent of Class Represented by Amount in Row (9)*

     

    8.9%

     

    Refer to Item 4 below.

    12  

    Type of Reporting Person (See Instructions)

     

    PN (Limited Partnership)

     


      1   

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Southpoint Capital Advisors LP

      2  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☒

     

      3  

    SEC Use Only

     

        

      4  

    Citizenship or Place of Organization.

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5    

    Sole Voting Power

     

    0 shares

       6   

    Shared Voting Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

       7   

    Sole Dispositive Power

     

    0 shares

       8   

    Shared Dispositive Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

      9  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,906,380 shares

     

    Refer to Item 4 below.

    10  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐  N/A

     

        

    11  

    Percent of Class Represented by Amount in Row (9)*

     

    8.9%

     

    Refer to Item 4 below.

    12  

    Type of Reporting Person (See Instructions)

     

    PN (Limited Partnership)

     


      1   

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Southpoint Capital Advisors LLC

      2  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☒

     

      3  

    SEC Use Only

     

        

      4  

    Citizenship or Place of Organization.

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5    

    Sole Voting Power

     

    0 shares

       6   

    Shared Voting Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

       7   

    Sole Dispositive Power

     

    0 shares

       8   

    Shared Dispositive Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

      9  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,906,380 shares

     

    Refer to Item 4 below.

    10  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐  N/A

     

        

    11  

    Percent of Class Represented by Amount in Row (9)*

     

    8.9%

     

    Refer to Item 4 below.

    12  

    Type of Reporting Person (See Instructions)

     

    OO (Limited Liability Company)

     


      1   

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Southpoint GP, LP

      2  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☒

     

      3  

    SEC Use Only

     

        

      4  

    Citizenship or Place of Organization.

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5    

    Sole Voting Power

     

    0 shares

       6   

    Shared Voting Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

       7   

    Sole Dispositive Power

     

    0 shares

       8   

    Shared Dispositive Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

      9  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,906,380 shares

     

    Refer to Item 4 below.

    10  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐  N/A

     

        

    11  

    Percent of Class Represented by Amount in Row (9)*

     

    8.9%

     

    Refer to Item 4 below.

    12  

    Type of Reporting Person (See Instructions)

     

    PN (Limited Partnership)

     


      1   

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Southpoint GP, LLC

      2  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☒

     

      3  

    SEC Use Only

     

        

      4  

    Citizenship or Place of Organization.

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5    

    Sole Voting Power

     

    0 shares

       6   

    Shared Voting Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

       7   

    Sole Dispositive Power

     

    0 shares

       8   

    Shared Dispositive Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

      9  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,906,380 shares

     

    Refer to Item 4 below.

    10  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐  N/A

     

        

    11  

    Percent of Class Represented by Amount in Row (9)*

     

    8.9%

     

    Refer to Item 4 below.

    12  

    Type of Reporting Person (See Instructions)

     

    OO (Limited Liability Company)

     


      1   

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    John S. Clark II

      2  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☐        (b)  ☒

     

      3  

    SEC Use Only

     

        

      4  

    Citizenship or Place of Organization.

     

    United States

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5    

    Sole Voting Power

     

    0 shares

       6   

    Shared Voting Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

       7   

    Sole Dispositive Power

     

    0 shares

       8   

    Shared Dispositive Power

     

    1,906,380 shares

     

    Refer to Item 4 below.

      9  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,906,380 shares

     

    Refer to Item 4 below.

    10  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐  N/A

     

        

    11  

    Percent of Class Represented by Amount in Row (9)*

     

    8.9%

     

    Refer to Item 4 below.

    12  

    Type of Reporting Person (See Instructions)

     

    IN

     


    Item 1.

     

      (a)

    Name of Issuer

    BCTG Acquisition Corp.

     

      (b)

    Address of Issuer’s Principal Executive Offices

    12860 El Camino Real, Suite 300

    San Diego, California 92130

     

    Item 2.

     

      (a)

    Name of Person Filing

    Southpoint Master Fund, LP

    Southpoint Capital Advisors LP

    Southpoint Capital Advisors LLC

    Southpoint GP, LP

    Southpoint GP, LLC

    John S. Clark II

     

      (b)

    Address of Principal Business Office or, if none, Residence

    1114 Avenue of the Americas, 22nd Floor

    New York, NY 10036

     

      (c)

    Citizenship

    Southpoint Master Fund, LP - Cayman Islands

    Southpoint Capital Advisors LP - Delaware

    Southpoint Capital Advisors LLC - Delaware

    Southpoint GP, LP - Delaware

    Southpoint GP, LLC - Delaware

    John S. Clark II - United States

     

      (d)

    Title of Class of Securities

    Common Stock, par value $0.0001 per share

     

      (e)

    CUSIP Number

    05492W 103


    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)     ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c)    ☐    Insurance Company as defined in Section 3(a)(19) of the Act
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
    (e)    ☐    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
    (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)    ☐    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

    Item 4.

    Ownership**

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    As of April 23, 2021, the Master Fund owned 1,906,380 shares of Common Stock, which is 8.9% of the Issuer’s outstanding Common Stock. The percentage herein is calculated based on 21,377,250 Common Stock outstanding as of March 31, 2021 as reported by the Issuer in its annual report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2021.

     

      (a)

    Amount Beneficially Owned***

    Southpoint Master Fund, LP – 1,906,380 shares

    Southpoint Capital Advisors LP - 1,906,380 shares

    Southpoint Capital Advisors LLC - 1,906,380 shares

    Southpoint GP, LP - 1,906,380 shares

    Southpoint GP, LLC - 1,906,380 shares

    John S. Clark II - 1,906,380 shares

     

      (b)

    Percent of Class

    Southpoint Master Fund, LP - 8.9%

    Southpoint Capital Advisors LP - 8.9%

    Southpoint Capital Advisors LLC - 8.9%

    Southpoint GP, LP - 8.9%

    Southpoint GP, LLC - 8.9%

    John S. Clark II - 8.9%


      (c)

    Number of shares as to which such person has:

     

      (i)

    sole power to vote or to direct the vote

    Southpoint Master Fund, LP - 0 shares

    Southpoint Capital Advisors LP - 0 shares

    Southpoint Capital Advisors LLC - 0 shares

    Southpoint GP, LP - 0 shares

    Southpoint GP, LLC - 0 shares

    John S. Clark II - 0 shares

     

      (ii)

    shared power to vote or to direct the vote

    Southpoint Master Fund, LP - 1,906,380 shares

    Southpoint Capital Advisors LP - 1,906,380 shares

    Southpoint Capital Advisors LLC - 1,906,380 shares

    Southpoint GP, LP - 1,906,380 shares

    Southpoint GP, LLC - 1,906,380 shares

    John S. Clark II - 1,906,380 shares

     

      (iii)

    sole power to dispose or to direct the disposition of

    Southpoint Master Fund, LP - 0 shares

    Southpoint Capital Advisors LP - 0 shares

    Southpoint Capital Advisors LLC - 0 shares

    Southpoint GP, LP - 0 shares

    Southpoint GP, LLC - 0 shares

    John S. Clark II - 0 shares

     

      (iv)

    shared power to dispose or to direct the disposition of

    Southpoint Master Fund, LP - 1,906,380 shares

    Southpoint Capital Advisors LP - 1,906,380 shares

    Southpoint Capital Advisors LLC - 1,906,380 shares

    Southpoint GP, LP - 1,906,380 shares

    Southpoint GP, LLC - 1,906,380 shares

    John S. Clark II - 1,906,380 shares

     

    **

    Shares reported herein are held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein.

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☐.


    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group

    Not applicable.

     

    Item 10.

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

    April 26, 2021

     

      SOUTHPOINT MASTER FUND, LP
      By:   Southpoint GP, LP, its General Partner
      By:   Southpoint GP, LLC, its General Partner
      By:  

    /s/ John S. Clark II

      John S. Clark II, Managing Member
      SOUTHPOINT CAPITAL ADVISORS LP
      By:  

    Southpoint Capital Advisors LLC,

    its General Partner

      By:  

    /s/ John S. Clark II

      John S. Clark II, Managing Member
      SOUTHPOINT CAPITAL ADVISORS LLC
      By:  

    /s/ John S. Clark II

      John S. Clark II, Managing Member
      SOUTHPOINT GP, LP
      By:  

    Southpoint GP, LLC,

    its General Partner

      By:  

    /s/ John S. Clark II

      John S. Clark II, Managing Member
      SOUTHPOINT GP, LLC
      By:  

    /s/ John S. Clark II

      John S. Clark II, Managing Member
      JOHN S. CLARK II
      By:  

    /s/ John S. Clark II

      John S. Clark II, individually


    JOINT FILING AGREEMENT

    This Joint Filing Agreement, dated as of April 26, 2021, is by and among Southpoint Master Fund, LP, Southpoint Capital Advisors LP, Southpoint Capital Advisors LLC, Southpoint GP, LP, Southpoint GP, LLC and John S. Clark II (collectively, the “Filers”).

    Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or 13G with respect to Common Stock of BCTG Acquisition Corp. beneficially owned by them from time to time.

    Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13D and/or 13G (and any amendments thereto) on behalf of each of the Filers, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.

    This Joint Filing Agreement may be terminated by any of the Filers upon written notice or such lesser period of notice as the Filers may mutually agree.

    Executed and delivered as of the date first above written.

     

    SOUTHPOINT MASTER FUND, LP
    By:   Southpoint GP, LP, its General Partner
    By:   Southpoint GP, LLC, its General Partner
    By:  

    /s/ John S. Clark II

    John S. Clark II, Managing Member
    SOUTHPOINT CAPITAL ADVISORS LP
    By:  

    Southpoint Capital Advisors LLC,

    its General Partner

    By:  

    /s/ John S. Clark II

    John S. Clark II, Managing Member
    SOUTHPOINT CAPITAL ADVISORS LLC
    By:  

    /s/ John S. Clark II

    John S. Clark II, Managing Member
    SOUTHPOINT GP, LP
    By:   Southpoint GP, LLC, its General Partner
    By:  

    /s/ John S. Clark II

    John S. Clark II, Managing Member
    SOUTHPOINT GP, LLC
    By:  

    /s/ John S. Clark II

    John S. Clark II, Managing Member

    /s/ John S. Clark II

    John S. Clark II
    Get the next $BCTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BCTG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BCTG
    SEC Filings

    View All

    SEC Form S-8 filed by BCTG Acquisition Corp.

    S-8 - Tango Therapeutics, Inc. (0001819133) (Filer)

    10/14/21 5:30:07 PM ET
    $BCTG
    Business Services
    Finance

    SEC Form 424B3 filed by BCTG Acquisition Corp.

    424B3 - Tango Therapeutics, Inc. (0001819133) (Filer)

    10/7/21 8:18:28 PM ET
    $BCTG
    Business Services
    Finance

    SEC Form EFFECT filed by BCTG Acquisition Corp.

    EFFECT - Tango Therapeutics, Inc. (0001819133) (Filer)

    9/30/21 12:15:16 AM ET
    $BCTG
    Business Services
    Finance

    $BCTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: Boxer Capital, LLC claimed ownership of 6,973,166 units of Common Stock

    3 - Tango Therapeutics, Inc. (0001819133) (Issuer)

    8/20/21 4:30:38 PM ET
    $BCTG
    Business Services
    Finance

    SEC Form 3: BCTG Holdings, LLC claimed ownership of 6,988,450 units of Common Stock

    3 - Tango Therapeutics, Inc. (0001819133) (Issuer)

    8/20/21 4:31:02 PM ET
    $BCTG
    Business Services
    Finance

    SEC Form 4 filed by Beckman Daniella

    4 - Tango Therapeutics, Inc. (0001819133) (Issuer)

    8/16/21 7:00:32 PM ET
    $BCTG
    Business Services
    Finance

    $BCTG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies

    – Business combination transaction with BCTG Acquisition Corp., a special purpose acquisition company sponsored by Boxer Capital, completed today – – Combined company Tango Therapeutics, Inc. will be listed on the Nasdaq Capital Market under ticker symbol "TNGX" – – Total expected cash position of approximately $515 million including gross proceeds from transaction totaling approximately $342 million, combining funds held in BCTG's trust account and PIPE financing once completed – CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. ("Tango Therapeutics" or "Tango"), a biotechnology company committed to discovering and delivering the next generation of prec

    8/10/21 9:00:00 AM ET
    $BCTG
    Business Services
    Finance

    Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies

    - Leading institutional investors commit $186 million through a common stock private investment in public equity ("PIPE") led by Boxer Capital - Total proceeds expected to be approximately $353 million, combining funds held in trust by BCTG Acquisition Corp and the PIPE financing - Merger expected to be completed in third quarter of 2021, and Combined Company will be listed on Nasdaq under the ticker "TNGX" – - Joint investor conference call to discuss the proposed transaction today, Wednesday, April 14, at 10:00 a.m. ET – Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. (NA

    4/14/21 8:30:00 AM ET
    $BCTG
    Business Services
    Finance

    $BCTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by BCTG Acquisition Corp.

    SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)

    9/10/21 12:17:18 PM ET
    $BCTG
    Business Services
    Finance

    SEC Form SC 13D filed by BCTG Acquisition Corp.

    SC 13D - Tango Therapeutics, Inc. (0001819133) (Subject)

    8/20/21 4:31:07 PM ET
    $BCTG
    Business Services
    Finance

    SEC Form SC 13G filed by BCTG Acquisition Corp.

    SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)

    8/19/21 4:59:28 PM ET
    $BCTG
    Business Services
    Finance